SPECTRUM PHARMACEUTICALS INC Quarterly Common Stock, Shares Authorized from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Spectrum Pharmaceuticals Inc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Common Stock, Shares Authorized for the quarter ending March 31, 2023 was 300M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 300M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 300M 0 0% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 300M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 300M 0 0% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 300M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 300M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 300M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 300M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 300M 0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 300M 0 0% Dec 31, 2020 10-K 2022-03-18
Q3 2020 300M 0 0% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 300M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 300M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 300M 0 0% Dec 31, 2019 10-K 2021-03-31
Q3 2019 300M 0 0% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 300M 0 0% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 300M +125M +71.4% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 300M 0 0% Dec 31, 2018 10-K 2020-03-02
Q3 2018 300M +125M +71.4% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 300M +125M +71.4% Jun 30, 2018 10-K 2022-03-18
Q1 2018 175M 0 0% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 300M +125M +71.4% Dec 31, 2017 10-K 2019-02-28
Q3 2017 175M 0 0% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 175M -125M -41.7% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 175M 0 0% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 175M 0 0% Dec 31, 2016 10-K 2018-03-07
Q3 2016 175M 0 0% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 300M +125M +71.4% Jun 30, 2016 10-K 2020-03-02
Q1 2016 175M 0 0% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 175M 0 0% Dec 31, 2015 10-K 2017-03-14
Q3 2015 175M 0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 175M 0 0% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 175M 0 0% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 175M 0 0% Dec 31, 2014 10-K 2016-03-14
Q3 2014 175M 0 0% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 175M 0 0% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 175M 0 0% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 175M 0 0% Dec 31, 2013 10-K 2015-03-13
Q3 2013 175M 0 0% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 175M 0 0% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 175M 0 0% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 175M 0 0% Dec 31, 2012 10-K 2014-03-12
Q3 2012 175M 0 0% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 175M 0 0% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 175M Mar 31, 2012 10-Q 2012-04-27
Q4 2011 175M 0 0% Dec 31, 2011 10-K 2013-02-28
Q3 2011 175M Sep 30, 2011 10-Q 2011-10-28
Q2 2011 175M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 175M Dec 31, 2010 10-K 2012-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.